Reading the tape
NASDAQ: BRKR
Bruker Corporation
Healthcare · Medical - Devices
Market Cap
$5.79B
52w High
$56.22
52w Low
$28.53
P/E
-671.80
Volume
2.56M
Outstanding Shares
152.22M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -6.68%Revenue (TTM): 2.08%FCF (TTM): -68.16%P/FCF: 100th pct
What changed
The stock fell 6.68% over the last year. Revenue grew 2.08% over the trailing twelve months. Operating margin moved from 7.52% to 5.44%. Free cash flow declined 68.16% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 5.44%. A decisive move in revenue — currently up 2.08% — would be the clearest signal to resolve the ambiguity.
Company profile
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally.
CEOFrank H. Laukien
SectorHealthcare
IndustryMedical - Devices
Employees11,396
IPO dateAug 4, 2000
Valuation
Forward P/E—
EV/EBITDA30.94
Enterprise value$8.9B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-0.24%
Gross margin46.62%▼6.91%vs FY2024
Operating margin5.44%▼16.17%vs FY2024
ROE-0.35%▼105.51%vs FY2024
Analyst consensus
RatingBuy
Target price$52.13▲37.15%
16
Buy
14
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est $0.23 · Revenue est $796.11M
View
Dividends
$0.20/shareQuarterly9yr growth streakSafeBRKR pays a dividend with a 0.53% dividend yield, 9 consecutive years of growth, growing at 4.56% annually, covered 1.9× by free cash flow.
Dividend Yield
0.53%
Annual Div / Share
$0.20
5yr CAGR
+4.56%
Doubles every ~15.5yr
Payout Ratio
—
Safe
Dividend Growth Rate
3yr CAGR
+0%
5yr CAGR
+4.56%
Dividend Safety
8/10Safe
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2025$0.20+0.0%
2024$0.20+0.0%
2023$0.20+0.0%
2022$0.20+17.6%
2021$0.17+6.2%
2020$0.16+0.0%
2019$0.16+0.0%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$5/yr
$0/mo
In 5 yrs
$7/yr+25%
$1/mo
In 10 yrs
$8/yr+56%
$1/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$5/yr $0/mo | $7/yr+25% $1/mo | $8/yr+56% $1/mo |
Yield-on-cost grows from 0.53% → 0.82% over 10yr
Analysis
Dividend Strengths
Well-covered by free cash flow
The dividend is covered 1.9× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Risks to Watch
No strong risk signal stands out from the latest period pair.